The administration of a 2AR inverse agonist (clozapine) in combination with a mGlu2 agonist (LY379268) was able to normalize Gq/11 to Gi/o signaling in patients with schizophrenia and consequently reduce the antipsychotic-like behavior [107]. This evidence concerns the gene GRM2 and schizophrenia.